Teijin and Axcelead to Establish Drug Discovery Research JV
Tokyo, Japan, February 20, 2023 — Teijin Limited and Axcelead, Inc. jointly announced today their basic agreement...
Axcelead DDP Selected as Project Partner for Harvard Business School Immersive Field Course
Axcelead Drug Discovery Partners Inc. (Head Office: Fujisawa, Kanagawa prefecture, CEO: Yoshinori Ikeura, “Axcelead DDP”) was...
Kaken Pharmaceutical and Axcelead DDP Begin Collaboration to Create Innovative New Drugs
Kaken Pharmaceutical Co., Ltd. (“Kaken”, Head Office: Bunkyo-ku, Tokyo; President and Representative Director, Hiroyuki Horiuchi) and Axcelead...
ThinkCyte and Axcelead DDP collaborate to advance novel phenotypic screening methods
Tokyo and Fujisawa, Japan. December 27, 2022: ThinkCyte and Axcelead Drug Discovery Partners (DDP) announced a research...
Axcelead DDP and Knowledge Palette Enter into a Collaborative Research Contract on Gene Expression Analysis Concerning Drug-Resistant Cancer
Axcelead Drug Discovery Partners Inc. (headquarters: Fujisawa, Kanagawa; CEO: Yoshinori Ikeura) and Knowledge Palette, Inc. (headquarters: Kawasaki,...
Axcelead Drug Discovery Partners and Acadia Pharmaceuticals Launch Drug Discovery Collaboration in Neuroscience
October 5, 2022 – Axcelead Drug Discovery Partners Inc. (HQ: Fujisawa, Kanagawa, Japan; hereinafter referred to as...